OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2025
(3)
2024
(3)
2022
(3)
2017
(2)
2016
(2)
2026
(1)
2023
(1)
2021
(1)
2020
(1)
2019
(1)
2015
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
The clinical spectrum of Caspr2 antibody-associated disease.
Not available
S-EPMC4970662
|
biostudies-literature
Cite
ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.
Not available
S-EPMC5350621
|
biostudies-literature
Cite
Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Not available
S-EPMC4836910
|
biostudies-literature
Cite
The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273.
Not available
S-EPMC8450229
|
biostudies-literature
Cite
B-cell responses to vaccination with BNT162b2 and mRNA-1273 6 months after second dose.
Not available
S-EPMC8897957
|
biostudies-literature
Cite
Mechanisms of Autoantibody-Induced Pathology.
Not available
S-EPMC5449453
|
biostudies-literature
Cite
Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis.
Not available
S-EPMC8479862
|
biostudies-literature
Cite
Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany.
Not available
S-EPMC9095476
|
biostudies-literature
Cite
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis.
Not available
S-EPMC11681429
|
biostudies-literature
Cite
A clinical approach to diagnosis of autoimmune encephalitis.
Not available
S-EPMC5066574
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets